Prognosis of COVID-19 patients with type 2 diabetes
1 Department of Internal Medicine, ASTER CMI Hospital, Hebbal, Bangalore, India.
2 Department of Endocrinology, ASTER CMI Hospital, Hebbal, Bangalore, India.
3 Patan Academy of Health Sciences - School of Medicine, Nepal.
Research Article
World Journal of Advanced Research and Reviews, 2021, 12(01), 126–139
Article DOI: 10.30574/wjarr.2021.12.1.0495
Publication history:
Received on 27 August 2021; revised on 03 October 2021; accepted on 05 October 2021
Abstract:
Background: The pandemic of COVID-19, a disease caused by novel coronavirus SARS-CoV-2, is associated with significant morbidity and mortality. Recent data showed that hypertension, diabetes mellitus, cardiovascular diseases, and chronic obstructive pulmonary disease were the most prevalent comorbidities in COVID-19 patients. Additionally, data indicate that hypertension, diabetes and cardiovascular diseases are important risk factors for progression and unfavourable outcome in COVID-19 patients. Poorly controlled Type 2 diabetes mellitus was associated with severe progression of disease. Hence, large studies with comprehensive analysis of all risk factors and longer follow-up are necessary.
Methods and analysis: A single-centre retrospective cross-sectional study of 300 patients that were SARS-CoV-2 positive from May to October 2020 was done. Data was entered into Microsoft excel data sheet and was analysed using SPSS 22 version software. Chi-square test or Fischer’s exact test (for 2x2 tables only) was used as test of significance for qualitative data. Independent t test was used as test of significance to identify the mean difference between two quantitative variables. ANOVA (Analysis of Variance) was used as test of significance to identify the mean difference between more than two quantitative variables. P value (Probability that the result is true) of <0.05 was considered as statistically significant after assuming all the rules of statistical tests.
Data collected was analyzed in a group of patients who were sub divided into 2 groups diabetics and Non diabetics. The parameters studied included laboratory markers: D dimer, CRP, Lactate Dehydrogenase, Ferritin levels. To assess the glycemic control HbA1C levels were assessed. The outcome parameters considered were Oxygen requirement, assessing the requirement of intensive care and duration of stay in the hospital
Conclusion: The patients with higher HbA1c values were found to have higher CRP and D-dimer values and required ICU shift and prolonged hospital stay. Hence, good control of diabetes will reduce the worsening of disease. In a country like India, where most of the population do not have health insurance cover proper control of diabetes, can reduce the burden on family. Hence, large studies with comprehensive analysis of all risk factors and longer follow-up are necessary.
Keywords:
Type 2 Diabetes mellitus; COVID-19; Inflammation; Prognosis
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0